These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22906206)

  • 1. Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplant for adult acute myelogenous leukemia.
    Kogut N; Tsai NC; Thomas SH; Palmer J; Paris T; Murata-Collins J; Forman SJ
    Leuk Lymphoma; 2013 Mar; 54(3):665-8. PubMed ID: 22906206
    [No Abstract]   [Full Text] [Related]  

  • 2. Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation.
    Heuser M; Gabdoulline R; Löffeld P; Dobbernack V; Kreimeyer H; Pankratz M; Flintrop M; Liebich A; Klesse S; Panagiota V; Stadler M; Wichmann M; Shahswar R; Platzbecker U; Thiede C; Schroeder T; Kobbe G; Geffers R; Schlegelberger B; Göhring G; Kreipe HH; Germing U; Ganser A; Kröger N; Koenecke C; Thol F
    Ann Hematol; 2017 Aug; 96(8):1361-1372. PubMed ID: 28612220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes.
    Harris AC; Kitko CL; Couriel DR; Braun TM; Choi SW; Magenau J; Mineishi S; Pawarode A; Yanik G; Levine JE
    Haematologica; 2013 Feb; 98(2):179-84. PubMed ID: 23065502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
    Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia.
    Ikegawa S; Doki N; Yamamoto K; Shingai N; Takahashi Y; Aoki J; Yoshioka K; Narukawa K; Ishida S; Igarashi A; Oshikawa G; Kobayashi T; Kakihana K; Sakamaki H; Haraguchi K; Okuyama Y; Ohashi K
    Leuk Lymphoma; 2015 Jun; 56(6):1874-7. PubMed ID: 25311493
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse.
    Pfeiffer T; Schleuning M; Mayer J; Haude KH; Tischer J; Buchholz S; Bunjes D; Bug G; Holler E; Meyer RG; Greinix H; Scheid C; Christopeit M; Schnittger S; Braess J; Schlimok G; Spiekermann K; Ganser A; Kolb HJ; Schmid C
    Haematologica; 2013 Apr; 98(4):518-25. PubMed ID: 22983588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.
    Yuda S; Fuji S; Onishi A; Tanaka T; Inamoto Y; Kurosawa S; Kim SW; Fukuda T
    Biol Blood Marrow Transplant; 2019 Jun; 25(6):1152-1157. PubMed ID: 30660773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia.
    Jang JE; Kim SJ; Cheong JW; Hyun SY; Kim YD; Kim YR; Kim JS; Min YH
    Ann Hematol; 2015 Feb; 94(2):275-82. PubMed ID: 25135450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
    Middeke JM; Fang M; Cornelissen JJ; Mohr B; Appelbaum FR; Stadler M; Sanz J; Baurmann H; Bug G; Schäfer-Eckart K; Hegenbart U; Bochtler T; Röllig C; Stölzel F; Walter RB; Ehninger G; Bornhäuser M; Löwenberg B; Schetelig J
    Blood; 2014 May; 123(19):2960-7. PubMed ID: 24652988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
    Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.
    Schmid C; Labopin M; Nagler A; Niederwieser D; Castagna L; Tabrizi R; Stadler M; Kuball J; Cornelissen J; Vorlicek J; Socié G; Falda M; Vindeløv L; Ljungman P; Jackson G; Kröger N; Rank A; Polge E; Rocha V; Mohty M;
    Blood; 2012 Feb; 119(6):1599-606. PubMed ID: 22167752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia.
    Segal E; Martens M; Wang HL; Brazauskas R; Weisdorf D; Sandmaier BM; Khoury HJ; de Lima M; Saber W
    Cancer; 2017 Sep; 123(17):3346-3355. PubMed ID: 28452054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploidentical
    Brissot E; Labopin M; Ehninger G; Stelljes M; Brecht A; Ganser A; Tischer J; Kröger N; Afanasyev B; Finke J; Elmaagacli A; Einsele H; Mohty M; Nagler A
    Haematologica; 2019 Mar; 104(3):524-532. PubMed ID: 30361416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated Extramedullary Relapse of Acute Leukemia after Allogeneic Stem Cell Transplantation: Different Kinetics and Better Prognosis than Systemic Relapse.
    Shem-Tov N; Saraceni F; Danylesko I; Shouval R; Yerushalmi R; Nagler A; Shimoni A
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1087-1094. PubMed ID: 28396161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.
    Chhabra S; Ahn KW; Hu ZH; Jain S; Assal A; Cerny J; Copelan EA; Daly A; DeFilipp Z; Gadalla SM; Gale RP; Ganguly S; Hamilton BK; Hildebrandt GC; Hsu JW; Inamoto Y; Kanate AS; Khoury HJ; Lazarus HM; Litzow MR; Nathan S; Olsson RF; Pawarode A; Ringden O; Rowe JM; Saad A; Savani BN; Schouten HC; Seo S; Shah NN; Solh M; Stuart RK; Ustun C; Woolfrey AE; Yared JA; Alyea EP; Kalaycio ME; Popat U; Sobecks RM; Saber W
    Blood Adv; 2018 Nov; 2(21):2922-2936. PubMed ID: 30396912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extramedullary disease at diagnosis of AML does not influence outcome of patients undergoing allogeneic hematopoietic cell transplant in CR1.
    Bourlon C; Lipton JH; Deotare U; Gupta V; Kim DD; Kuruvilla J; Viswabandya A; Thyagu S; Messner HA; Michelis FV
    Eur J Haematol; 2017 Sep; 99(3):234-239. PubMed ID: 28556258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
    Brissot E; Labopin M; Stelljes M; Ehninger G; Schwerdtfeger R; Finke J; Kolb HJ; Ganser A; Schäfer-Eckart K; Zander AR; Bunjes D; Mielke S; Bethge WA; Milpied N; Kalhs P; Blau IW; Kröger N; Vitek A; Gramatzki M; Holler E; Schmid C; Esteve J; Mohty M; Nagler A
    J Hematol Oncol; 2017 Jun; 10(1):130. PubMed ID: 28646908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation associated with improved survival?
    Curley C; Durrant S; Kennedy GA
    Asia Pac J Clin Oncol; 2013 Sep; 9(3):285-9. PubMed ID: 23418909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.